375.12美元5.21(1.41%)
2022/08/10更新
績效 / 1月0.31%
3月1.77%
1年8.18%
晨星評等 - 1.現金0.00%
- 2.股票37.86%
- 3.債券0.00%
- 4.其他62.14%
- 1.美國62.14%
- 2.歐洲不包含歐元區21.46%
- 3.日本5.95%
- 4.英國4.75%
- 5.歐元區3.05%
- 1.健康護理95.53%
- 2.工業2.16%
- 3.基本物料1.37%
- 4.防守性消費0.95%
- 1.UnitedHealth Group Inc10.65%
- 2.Roche Holding AG6.97%
- 3.Novo Nordisk A/S Class B6.89%
- 4.Amgen Inc6.40%
- 5.Elevance Health Inc5.65%
- 6.Vertex Pharmaceuticals Inc5.30%
- 7.GSK PLC4.75%
- 8.Pfizer Inc4.42%
- 9.Regeneron Pharmaceuticals Inc3.39%
- 10.Zoetis Inc Class A3.09%
- 1.現金0.00%
- 2.股票37.86%
- 3.債券0.00%
- 4.其他62.14%
- 1.健康護理95.53%
- 2.工業2.16%
- 3.基本物料1.37%
- 4.防守性消費0.95%
- 1.美國62.14%
- 2.歐洲不包含歐元區21.46%
- 3.日本5.95%
- 4.英國4.75%
- 5.歐元區3.05%
- 1.UnitedHealth Group Inc10.65%
- 2.Roche Holding AG6.97%
- 3.Novo Nordisk A/S Class B6.89%
- 4.Amgen Inc6.40%
- 5.Elevance Health Inc5.65%
- 6.Vertex Pharmaceuticals Inc5.30%
- 7.GSK PLC4.75%
- 8.Pfizer Inc4.42%
- 9.Regeneron Pharmaceuticals Inc3.39%
- 10.Zoetis Inc Class A3.09%